Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guérin (BCG) results in the release of functional soluble TRAIL/Apo-2L

Mycobacterium bovis bacillus Calmette-Guérin (BCG) has been used to treat bladder cancer for almost 30 years; however, the effector mechanism of the BCG-induced antitumor response remains enigmatic. Most BCG research has focused on the mononuclear-cell infiltrate, but growing evidence supports a rol...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kemp, Troy J., Ludwig, Aaron T., Earel, James K., Moore, Jill M., VanOosten, Rebecca L., Moses, Bonita, Leidal, Kevin, Nauseef, William M., Griffith, Thomas S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: The American Society of Hematology 2005
Soggetti:
Immunobiology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895062/
https://ncbi.nlm.nih.gov/pubmed/16037389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-03-1327
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi